Latest news with #Lexapro
Time Business News
6 days ago
- Health
- Time Business News
Parents' Experiences: Strattera vs Adderall for Young Kids
When a child is diagnosed with ADHD, parents often face the difficult decision of choosing the most suitable treatment. Two of the most commonly prescribed medications are Strattera vs adderall. While both aim to help manage ADHD symptoms, they differ significantly in how they work and affect children. Understanding how other parents perceive these medications can provide valuable insight for those navigating this challenging decision. When it comes to treating anxiety and depression, finding the right medication can be a complex decision. Two commonly prescribed SSRIs are Lexapro vs zoloft, each with unique effects on mood and potential side effects. While both medications work by increasing serotonin levels in the brain, they may differ in how quickly they act or how well they're tolerated by different individuals. Factors like your medical history, other medications, and potential side effects should be considered. Consulting with a healthcare provider is essential to determine which option aligns best with your personal needs and treatment goals. Strattera is a non-stimulant medication that works by increasing levels of norepinephrine in the brain. Unlike Adderall, which is a stimulant, Strattera does not have immediate effects and may take several weeks to show benefits. Adderall, on the other hand, is a fast-acting stimulant that affects dopamine and norepinephrine levels, leading to a quicker response in terms of symptom management. These fundamental differences lead to varying experiences among parents and children. Many parents approach ADHD medications with caution, especially when the child is young. One common concern is the fear of personality changes or emotional blunting. Parents who chose Strattera often mention that they preferred starting with a non-stimulant to avoid the potential for stimulant-related side effects, such as sleep disturbances or appetite suppression. Others opted for Adderall because of the immediate need for symptom control, especially if behavioral issues were affecting school performance. Parents who have used Strattera for their children often describe the experience as a slow but steady journey. It typically takes several weeks to notice any improvement, which can test a parent's patience. However, many appreciate the subtle nature of the changes. One mother of a seven-year-old mentioned that her son became 'more thoughtful and less reactive' over time, without feeling sedated or overly quiet. Another parent shared that Strattera helped improve her daughter's emotional regulation and focus in school, with fewer emotional outbursts at home. However, the slower onset of action also proved frustrating for some. A few parents noted that their children did not respond to Strattera even after the full trial period, and they had to eventually switch to a stimulant. Side effects such as stomachaches, mood swings, or fatigue were also reported by some families, although they often resolved after dosage adjustments. Parents who opted for Adderall often report quicker results, sometimes within the first day or week of treatment. Many noted dramatic improvements in attention span, classroom behavior, and overall school performance. A father of a six-year-old shared that his son 'could finally sit through a lesson and follow instructions,' something that seemed impossible before starting Adderall. Others echoed this sentiment, saying their child was more engaged and less impulsive, both in school and at home. Despite its effectiveness, Adderall's side effects were a significant concern for many parents. Common issues included appetite suppression, difficulty sleeping, and increased irritability, particularly when the medication wore off in the evening. Some children experienced emotional crashes or became overly focused, leading to rigidity in thinking or behavior. One parent described how her daughter became 'laser-focused but anxious,' prompting a reevaluation of the dosage and timing. Many parents emphasized that medication, whether Strattera or Adderall, was just one part of a broader ADHD management plan. Behavioral therapy, consistent routines, diet changes, and strong communication with teachers were often mentioned as essential components. Parents appreciated doctors who took a holistic approach and encouraged regular check-ins to monitor the child's progress and adjust treatment accordingly. Some parents also found success in switching between medications or combining low doses of both under medical supervision. For example, a mother described starting her son on Strattera and later adding a small dose of Adderall to target specific school hours, which helped reduce side effects while maintaining effectiveness. Navigating ADHD treatment is not just a medical decision—it's an emotional journey. Parents often expressed feelings of guilt, worry, and self-doubt, especially during the early stages of treatment. Seeing improvements in their child's ability to function and succeed brought relief and even joy. At the same time, dealing with side effects or trial-and-error periods was emotionally draining. Several parents mentioned the importance of parent support groups, either in person or online, where they could share experiences and receive guidance. Children, too, were affected emotionally by their treatment experience. Some became more confident as they gained control over their behavior and received positive feedback from teachers. Others struggled with the stigma of taking medication or experienced self-esteem issues related to side effects. Open conversations, reassurance, and involving the child in age-appropriate decisions helped many families navigate these challenges. Every child with ADHD is unique, and so are their responses to medications like Strattera and Adderall. The experiences of parents reveal that while some children thrive on one medication, others may struggle. The key is working closely with healthcare providers, being patient during the trial period, and focusing on the child's overall well-being rather than just symptom control. Whether choosing Strattera for its gradual, non-stimulant benefits or Adderall for its quick symptom relief, parents play a crucial role in advocating for their child's needs and ensuring a balanced, personalized treatment approach. Their voices remind us that the journey may be complex, but with support and persistence, improvement is possible. TIME BUSINESS NEWS
NBC News
21-07-2025
- Health
- NBC News
FDA panel promotes misinformation on antidepressants during pregnancy, psychiatrists say
A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to misinformation or facts taken out of context, according to several psychiatrists who tuned into the meeting. The panel had promised to feature diverse viewpoints about antidepressants and pregnancy. But nearly all of the 10 panelists bucked medical consensus on the drugs' safety and emphasized what they said were risks of taking the drugs while pregnant— such as causing autism, miscarriages or birth defects. In some cases, they claimed that antidepressants do not work at all and depression goes away on its own. Three of the 10 panelists were from outside the U.S. Another runs a clinic to help people taper off of psychiatric drugs. 'They were really rousing concerns about safety that are not evidence-based or established, and not at all balanced with concerns about the risks of untreated depression,' said Dr. Joseph Goldberg, a clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York City. 'I'm disappointed that the FDA brought people in from outside of the United States when there's so many experts here in the United States who truly know this [medical] literature inside and out,' added Dr. Jennifer Payne, director of the Reproductive Psychiatry Research Program at the University of Virginia. A spokesperson for the FDA said the claim that the panel was one-sided was 'insulting to the independent scientists, clinicians, and researchers who dedicate their expertise to these panels.' The spokesperson added that '[FDA] Commissioner Makary has an interest in ensuring policies reflect the latest gold standard science and protect public health.' Health and Human Services Secretary Robert F. Kennedy Jr. has called for a probe into the risks of antidepressants. His 'Make America Healthy Again' report in May claimed there were 'potentially major long-term repercussions' associated with use of the drugs in childhood. The panel discussion focused on a class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, which includes Lexapro, Prozac and Zoloft. The medications increase levels of serotonin, a chemical messenger in the brain that can improve mood. Psychiatrists often advise women who are taking SSRIs to continue doing so during pregnancy, since the risks of untreated depression tend to outweigh the potential risks of the medication to mother and child. However, the decision is a personal one. For ethical reasons, there are no randomized-control trials of SSRIs in pregnant women, meaning that data on potential risks mostly comes from observational studies and drug registries. Some babies born to mothers taking SSRIs may develop symptoms such as jitteriness, irritability or difficulty eating or sleeping that resolve quickly — what's known as 'neonatal adaptation syndrome.' The symptoms may be caused by medication in the baby's system or withdrawal from it. Certain studies have also found a slightly elevated risk of miscarriage associated with antidepressant use in pregnancy, though others have found no association. However, there's no convincing evidence to suggest that SSRIs are linked to autism or birth defects. 'Well-controlled studies continue to not find an association,' Payne said. Women with a history of depression are also at an increased risk of symptoms recurring during pregnancy, and depression can come with its own risks — including thoughts of self-harm or low birth weight. 'The best thing a pregnant individual could do for herself and her baby is to get the treatment that they need,' said Dr. Nancy Byatt, a perinatal psychiatrist at UMass Chan Medical School, who was not part of the panel. In addition to raising concerns about side effects, several panelists questioned the efficacy of antidepressants or suggested that data favoring the use of SSRIs was manipulated by the pharmaceutical industry. 'It's been said that SSRIs help people who are severely depressed. They don't,' said David Healy, an FDA panelist and fellow at the Royal College of Psychiatrists in the United Kingdom. Goldberg and other psychiatrists said that's simply untrue. 'You can say the moon landing was faked. Conspiracy theories abound in our world. But there is not a doubt about whether SSRIs work,' said Goldberg, a past president of the American Society of Clinical Psychopharmacology who has previously consulted for pharmaceutical companies. He said he was invited to join the FDA panel, but declined because the language of the invitation suggested it would not be a fair discussion. Healy, the panelist, also claimed that some people 'recover spontaneously' from depression. Another panelist, psychologist Roger McFillin — who hosts a podcast that challenges conventional mental health advice — suggested that depression was not an illness, but rather a product of 'women just naturally experiencing their emotions more intensely.' He added, without evidence, that many women feel coerced into taking antidepressants. Psychiatrists who weren't part of the discussion broadly decried those characterizations. 'I have never, ever, ever, ever heard of a third party pushing a prescription in pregnancy,' Goldberg said. However, he said he is aware of some obstetrician-gynecologists who aren't as familiar with SSRIs wrongly telling pregnant patients to stop taking the medications. The American College of Obstetricians and Gynecologists said in a statement on Monday that SSRIs can be lifesaving for some pregnant individuals. 'Today's FDA panel on SSRIs and pregnancy was alarmingly unbalanced and did not adequately acknowledge the harms of untreated perinatal mood disorders in pregnancy,' the organization said. 'On a panel of 10 experts, only one spoke to the importance of SSRIs in pregnancy as a critical tool, among others, in preventing the potentially devastating effects of anxiety and depression when left untreated during pregnancy.' One panelist, Dr. Kay Roussos-Ross, a psychiatrist and an OB-GYN at the University of Florida College of Medicine, was the most vocal advocate for the use of SSRIs, often pushing back against others' assessments of the risks. Psychiatrists who weren't on the panel praised her science-backed commentary. 'All of us can find a study that agrees with exactly what we think,' Roussos-Ross told the panel. 'But we need to look at the data very objectively.' Several psychiatrists who weren't on the panel said they worry the discussion could lead to regulatory action that makes it harder to access SSRIs. For example, panelist Dr. Adam Urato, chief of maternal-fetal medicine at MetroWest Medical Center in Framingham, Massachusetts, called for stronger warnings on SSRI labels. 'I am just very nervous that some of the discourse around the risks of antidepressants could lead to even more barriers for people seeking care,' said Dr. Lindsay Lebin, an assistant professor of psychiatry at the University of Colorado Anschutz Medical Campus, who was not part of the FDA discussion.
Time Business News
15-07-2025
- Health
- Time Business News
Understanding ADHD and Its Treatment Landscape
Attention-deficit/hyperactivity disorder (ADHD) affects millions of children and adults worldwide, manifesting in symptoms such as inattentiveness, impulsivity, and hyperactivity. Treatment options for ADHD range from behavioral therapies and lifestyle adjustments to pharmaceutical interventions and natural supplements. Among prescription medications, strattera vs adderall are two of the most commonly used drugs. However, a growing number of individuals and caregivers are exploring natural ADHD supplements as alternative or complementary options, driven by concerns over side effects, dependency, and long-term health. This article compares natural ADHD supplements with Strattera and Adderall, examining efficacy, safety, and practical considerations. When deciding on the most effective treatment for depression or anxiety, understanding how medications differ is essential. Two commonly prescribed options, lexapro vs zoloft, often come up in discussions between patients and doctors. While both are selective serotonin reuptake inhibitors (SSRIs), Lexapro (escitalopram) is typically noted for its simplicity in dosing and potentially fewer side effects. Zoloft (sertraline), on the other hand, may be more effective for certain anxiety-related conditions. The choice between them depends on individual response, side effect tolerance, and mental health history. Consulting a healthcare provider is the best way to determine which is right for you. Natural ADHD supplements typically include a combination of vitamins, minerals, herbs, and amino acids intended to support brain function, focus, mood regulation, and impulse control. Common ingredients include omega-3 fatty acids, magnesium, zinc, iron, L-theanine, GABA, and herbal extracts like ginkgo biloba and Rhodiola rosea. These supplements are often marketed as being free of synthetic chemicals and side effects. While scientific evidence supporting their efficacy varies, many people report positive outcomes, particularly when used in conjunction with behavioral interventions. Adderall is a combination of amphetamine salts that works by increasing the levels of dopamine and norepinephrine in the brain. These neurotransmitters are associated with attention, motivation, and impulse control. Adderall is widely prescribed and generally effective at reducing core ADHD symptoms. However, it is a Schedule II controlled substance due to its high potential for abuse and dependency. Common side effects include insomnia, anxiety, decreased appetite, elevated heart rate, and mood swings. Long-term use can lead to tolerance, requiring higher doses to maintain efficacy, and abrupt discontinuation can trigger withdrawal symptoms. Strattera (atomoxetine) is one of the few non-stimulant medications approved for ADHD. Unlike Adderall, Strattera targets norepinephrine rather than dopamine, and it's not classified as a controlled substance. This makes it a preferable option for individuals at risk for substance abuse or those who cannot tolerate stimulants. Strattera's side effects may include drowsiness, dry mouth, nausea, decreased appetite, and mood changes. While it has a slower onset of action—often requiring several weeks to achieve full effects—it tends to have a more stable, all-day coverage compared to stimulant medications. Pharmaceuticals like Adderall and Strattera tend to provide more immediate and predictable symptom relief. Numerous clinical trials support their use, and physicians can fine-tune dosages based on individual response. In contrast, natural supplements generally lack the robust scientific backing found with pharmaceuticals. That said, some supplements—particularly omega-3 fatty acids, magnesium, and zinc—have shown promise in clinical studies. Their effectiveness may be more subtle and cumulative, improving overall brain health rather than targeting specific symptoms acutely. For individuals with mild to moderate ADHD or those who prioritize a holistic approach, natural supplements may offer a gentler, sustainable solution. One of the most significant advantages of natural ADHD supplements is their favorable safety profile. Most are well-tolerated, with minimal side effects when taken at recommended doses. In contrast, both Adderall and Strattera can cause a range of adverse effects. Stimulant medications, in particular, carry cardiovascular risks and can exacerbate anxiety or lead to behavioral rebound effects as the medication wears off. For parents concerned about medicating young children or adults wary of becoming dependent on prescription drugs, natural alternatives provide a reassuring option. Another critical consideration is how customizable and accessible each treatment is. Prescription medications require a doctor's diagnosis and ongoing monitoring, which can be both costly and time-consuming. Dosage adjustments may take time, and individuals may need to try multiple medications before finding one that works. Natural supplements are generally more accessible and can be purchased over-the-counter or online. This ease of access allows individuals to experiment with different combinations to find what best supports their needs. However, this also introduces the risk of inconsistent quality or inadequate dosing, particularly without professional guidance. Natural ADHD supplementation often goes hand-in-hand with broader lifestyle interventions. Diet plays a significant role in managing ADHD symptoms, and a nutrient-dense, balanced diet can enhance the effectiveness of natural supplements. Exercise, mindfulness, sleep hygiene, and behavioral therapy all contribute to improved outcomes. While pharmaceuticals can be effective on their own, combining them with lifestyle changes tends to yield the best long-term results. In this way, natural treatments encourage a more integrative, holistic approach to ADHD management. While each treatment modality has its strengths, over-reliance on a single approach—be it pharmaceuticals or supplements—can be problematic. Adderall and Strattera may provide fast relief but can mask underlying issues or discourage the pursuit of behavioral strategies. Conversely, natural supplements may not offer sufficient relief for individuals with severe ADHD. The most effective treatment plans are often those that combine elements from both camps: targeted medication for acute symptom control, and natural supplements or lifestyle interventions to support overall cognitive health. One downside of natural supplements is the lack of strict regulatory oversight. Unlike pharmaceuticals, which undergo rigorous FDA approval and manufacturing standards, supplements are not held to the same level of scrutiny. This leads to variability in quality, potency, and purity. Some products may contain harmful additives or fail to deliver the advertised ingredients. To mitigate this, consumers should look for third-party tested brands and consult healthcare professionals before beginning any new supplement regimen. Choosing between natural ADHD supplements and medications like Strattera or Adderall is a deeply personal decision that should be guided by severity of symptoms, individual health profile, and lifestyle preferences. For children or adults with moderate to severe ADHD, pharmaceuticals may offer the structure and immediate symptom relief necessary to thrive in academic or work environments. For those with milder symptoms or significant concerns about medication side effects, natural supplements offer a low-risk, potentially effective alternative. In many cases, a hybrid approach—using low-dose medication supported by targeted supplementation and behavioral interventions—strikes the best balance. The debate between natural ADHD supplements and conventional medications like Adderall and Strattera reflects a broader conversation in mental health: the need to tailor treatments to the whole person, not just the diagnosis. While pharmaceutical treatments remain the gold standard in terms of efficacy, natural supplements are gaining traction for their safety, accessibility, and holistic benefits. Ultimately, working with a knowledgeable healthcare provider to evaluate all options ensures that individuals with ADHD can make informed, empowered choices that support both immediate needs and long-term well-being. TIME BUSINESS NEWS
Time of India
14-07-2025
- Entertainment
- Time of India
Azealia Banks calls out Conor McGregor over explicit DMs after Bebe Rexha feud: A look back at both explosive spats
Azealia Banks is once again in the spotlight, this time accusing former UFC champion Conor McGregor of sending her explicit, unsolicited messages on Instagram. The controversy arrives just months after Banks made headlines for a heated online feud with pop star Bebe Rexha following the latter's Met Gala appearance. Both cases quickly went viral, stirring debates online about personal boundaries, celebrity behaviour, and online retaliation. Bebe Rexha and Azealia Banks: The May 2025 exchange The first public flashpoint came in May 2025, when Banks commented on Bebe Rexha's Met Gala outfit in a post on X, formerly Twitter. Her remarks included speculation about Rexha's health and body, suggesting that the singer might be using hormonal treatments like implants or birth control shots. Rexha responded strongly, asking Banks to seek therapy and noting that she had found help through Lexapro. She added that healing 'looks good on everyone.' In later posts, Rexha disclosed her struggles with PCOS and a recent pregnancy loss, explaining that unsolicited commentary on her weight had added to her pain. Despite Rexha's candid response, Banks continued posting, blaming Lexapro for her own past health issues and saying the medication made her gain weight. She also described her shift from antidepressants to natural supplements, maintaining her unapologetic tone throughout. New trouble with McGregor: Allegations surface in July 2025 In July 2025, Banks shared screenshots on X alleging that Conor McGregor sent her explicit images via Instagram direct message. The photos reportedly showed the MMA fighter unclothed in what appeared to be a closet. One of the messages warned her not to disclose the content, stating, 'Don't be a rat cos all rats get caught.' doechii and azealia banks using nicki's lyrics to drag each other is so funny 😭😭 Banks reacted by questioning McGregor's recent political aspirations, referencing his online campaign for the Irish presidency. She commented on his appearance, urged him to use sunscreen, and criticized his alleged attempt at intimidation. She later shared that the messages had been deleted, adding, 'The motherf***** woke up early LOL.' McGregor's controversial history resurfaces This is not the first time McGregor has faced public scrutiny. His last UFC appearance was in July 2021, and his anticipated return in 2024 was cancelled due to a toe injury. He was also reportedly involved in a physical altercation at a nightclub in Ibiza earlier this year. In 2023, a civil case found McGregor liable for sexual assault, following allegations made by Nikita Hand. The court proceedings concluded that the two had engaged in sexual activity, though the nature of the incident was disputed. McGregor claimed it was consensual. Banks' pattern of online clashes With both incidents — the Rexha exchange and the McGregor accusations — Banks has kept her confrontational stance consistent. Whether commenting on another celebrity's health or sharing serious allegations, she continues to use social media as her main platform. These events reflect how quickly personal matters between public figures can escalate online, drawing in millions and often leaving lasting impact — not just on reputations, but on wider discussions around mental health, digital safety, and accountability.
Metro
12-07-2025
- Entertainment
- Metro
Pussycat Dolls icon reveals startling details of drug addiction for first time
Ashley Roberts, best known as one-fifth of the Pussycat Dolls, has revealed for the first time the details of her decades-long battle with prescription drug dependence. The hidden struggle that began in her teenage years and shadowed her rise to global pop fame. Now 42, the pop star described how her addiction to the anti-anxiety medication Xanax began during high school, part of a long trajectory of self-soothing with substances. Even as a child, she turned to over-the-counter sleep aids like NyQuil. In adulthood, Lexapro followed, and then Xanax became a near-daily crutch. 'I was so young and I didn't have the knowledge I have now,' Roberts reflected in a new interview with The Times. 'Xanax is addictive. For me, for decades I was just leaning on what I could get to help me crash out. My brain just wouldn't shut off and my anxiety was too intense.' Discovered in Los Angeles by Pussycat Dolls founder Robin Antin, she joined the group in 2003 at just 22. Their 2005 debut album PCD became a multi-platinum global hit, propelling them onto a relentless international tour schedule. 'There were no discussions around, 'How is your mental health?'' Roberts said. 'I remember once we were in three countries in one day. Eventually, my body just got to the point of shutdown. I was really, really sick.' The breaking point came in London, nearly five years after the band's meteoric rise. Roberts was admitted to hospital with suspected neurological damage and medics feared she'd suffered a brain aneurysm. It was later diagnosed as extreme stress, exhaustion, and burnout, worsened by chronic sleep deprivation, poor nutrition, and unmanaged anxiety. Despite the crisis, she remained locked into performance-mode: 'I remember saying [in the hospital], 'I need to get on a flight to Germany. I've got a show to do. You gotta give me something.' That was the mentality.' When she finally left the group in 2010, Roberts's body was in turmoil: she had shingles across her face, eczema covering her legs, a stomach ulcer, and a collapsed immune system. More Trending 'An acupuncturist told me then, 'If you don't scream, your body's gonna scream for you,'' she recalled. While Roberts avoids placing blame directly on the male-dominated music industry, her story lays bare the punishing realities of commercial pop at the time – a culture that encouraged silence, competition, and constant productivity. 'There was also this feeling that we could be replaced in some way,' she said, 'But also there was my own drive, growing up as a dance competitor. So it was a combination of the two.' Now living a more grounded life, Roberts credits breathwork (a therapeutic practice of conscious breathing) with helping her finally break free from dependency and reconnect with her body. Got a story? If you've got a celebrity story, video or pictures get in touch with the entertainment team by emailing us celebtips@ calling 020 3615 2145 or by visiting our Submit Stuff page – we'd love to hear from you.
